JASON OBERDICK: Open Payments
NPI 1316027774 · WEXFORD, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,247 in 334 payments from 22 companies in 2025. Trend: 2023 $59,196 · 2024 $45,845 · 2025 $5,247
Food & beverage: $4,747Consulting: $500
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 87 | $1,068 |
| Janssen Biotech, Inc. | 52 | $634 |
| Journey Medical Corporation | 3 | $511 |
| GENZYME CORPORATION | 17 | $465 |
| UCB, Inc. | 32 | $464 |
| LEO Pharma Inc. | 20 | $357 |
| Galderma Laboratories, L.P. | 25 | $318 |
| Lilly USA, LLC | 15 | $229 |
| PFIZER INC. | 14 | $201 |
| E.R. Squibb & Sons, L.L.C. | 18 | $174 |
Products named: RINVOQ, TREMFYA, DUPIXENT, Bimzelx, SKYRIZI, NEMLUVIO, ADBRY, CIBINQO.
Industry payments across PA — which companies pay providers there.
